Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

The prohibition halts support for projects both inside and outside the N.I.H. President Biden had restored funding after an ...

The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.

As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...

Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...

If you feel like everyone you know is dealing with a cough, cold and runny nose, it’s not in your head. Multiple viruses, not ...

With RSV cases on the rise, an Annenberg survey finds most Americans would be likely to recommend the RSV vaccine to older adults and pregnant people and the monoclonal antibody injection for infants.

NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) and the SPEAR Study Group today announced the plan to initiate a Phase 2 clinical trial evaluating monoclonal antibody ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

If you’re older than 12 and test positive for COVID-19, you most likely qualify to receive monoclonal antibody treatment on Texas’ dime. For most, the largest barrier to getting the early-stage ...